🔎 Trials Near Me

Home › Type 2 Diabetes › North Carolina › Havelock

Pag-aaral pangklinika para sa Type 2 Diabetes sa Havelock, NC

Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Havelock. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Nagre-recruitPhase 3
  • West Clinical Research, Morehead City · 15 mi ang layo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684144

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Nagre-recruitPhase 3
  • Centricity Research - Morehead City, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Nagre-recruitPhase 3
  • Lucas Research, Inc., Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07064473

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Nagre-recruitPhase 3
  • West Clinical Research, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3
  • AURORA-2 Clinical Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Nagre-recruitPhase 3
  • Centricity Research Morehead City Multispeciality, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Nagre-recruitPhase 2
  • Lucas Research, Inc., Morehead City · 15 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06897475

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Nagre-recruitPhase 2
  • Lucas Research Inc, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07296484

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Nagre-recruitPhase 3
  • Research Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07662213

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Nagre-recruit
  • Centricity Research - Morehead City, Morehead City · 15 mi ang layo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599982

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Nagre-recruitPhase 2
  • Lucas Research, Inc., Morehead City · 15 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07527650

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Nagre-recruitPhase 3
  • Research Site, Morehead City · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07664553

Pag-aaral para sa Type 2 Diabetes sa ibang lungsod

Iba pang pag-aaral sa Havelock

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.